RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer
Figure 4
Ran and TPX2 expressions are associated with a short progression free survival in high-grade serous carcinoma.
Evaluation of RAN network protein expression in only high-grade serous carcinomas by Kaplan–Meier analysis. Progression free survival corresponds to the time in months calculated from the time of first surgery until the first progression. The log-rank test was used to define statistical difference between groups. (See Figure 3 legend for details).